PTC Therapeutics Files For IPO Of Up To $85M
May 17, 2013
PTC Therapeutics Inc., which develops drugs that target post-transcriptional control processes, has filed to raise up to $85 million in an initial public offering (IPO) of its common stock. PTC's lead product candidate is ataluren for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. read on...
Tableau Software (DATA) Shares Spike 60 Pct In IPO Debut
May 17, 2013
Tableau Software Inc. (NYSE: DATA), a provider of data analytics and visualization products, raised about $254 million after pricing its initial public offering (IPO) of 8.2 million shares of its Class A common stock at $31.00 each. The shares, which opened for trading at $47.00, jumped as much as 61 percent to $49.82 early Friday. read on...
Tableau Software Increases IPO Price Range
May 16, 2013
Tableau Software Inc., a provider of data analytics and visualization products, raised the proposed pricing range of its initial public offering (IPO) of Class A common stock. The Seattle-based company currently plans to sell 7.2 million shares at between $28 and $30 apiece, up from $23 to $26 proposed earlier. read on...